Pericyazine
Cat. No.：YN1730062
CAS No. ：2622-26-6
| 产品名称: | Pericyazine |
| CAS No.: | 2622-26-6 |
| Chemical Name: | 10-[3-(4-hydroxy-1-piperidinyl)propyl]-10H-phenothiazine-2-carbonitrile |
| Synonyms: | Propericiazine; RP 8909 |
| 分子量: | 365.49 |
| 分子式: | C₂₁H₂₃N₃OS |
| SMILES: | N#CC(C=C1N2CCCN3CCC(O)CC3)=CC=C1SC4=C2C=CC=C4 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Pericyazine (Propericiazine) 是第一代抗精神病药物，被用作短期管理严重焦虑状态和精神病的辅助药物。Pericyazine (Propericiazine) 是一种选择性的 D2 多巴胺受体 (D2-dopamine receptor) 拮抗剂。Pericyazine 具有肾上腺溶解、抗胆碱能和锥体外系作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Kanba, S., Suzuki, E., Nomura, S., et al.Affinity of neuroleptics for D1 receptor of human brain striatumJ. Psychiatry Neurosci.19(4),265-269(1994)
Bisson, W.H., Cheltsov, A.V., Bruey-Sedano, N., et al.Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugsProc. Natl. Acad. Sci. USA104(29),11927-11932(2007)
Megens, A.A.H.P., Leysen, J.E., Awouters, F.H.L., et al.Further validation of in vivo and in vitro pharmacological procedures for assessing the ɑ2/ɑ1-selectivity of test compounds: (1) ɑ-adrenoceptor antagonistsEur. J. Pharmacol.129(1-2),49-55(1986)
Ghahremanpour, M.M., Tirado-Rives, J., Deshmukh, M., et al.Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2ACS Med. Chem. Lett.11(12),2526-2533(2020)
Cechin, E.M., Quevedo, J., Barichello, T., et al.Dose-related effects of propericiazine in ratsBraz. J. Med. Biol. Res.36(2),227-231(2003)
